Integrated BioPharma Inc (INBP) stock
INBPOTCPharmaceutical PreparationsFiscal year ends June 30
$0.18+0.00 (0.00%)
Close on Oct 19, 2026Market cap $5.59MP/E –Yield –
Integrated BioPharma operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Integrated BioPharma's operating cash flow for the twelve months ending Jun 30, 2026 was $1.24M, down 39.9% year over year. For fiscal 2026 it was $1.24M, down 39.9% from the year before. The highest annual figure on record is $4.09M in fiscal 2022.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $1.24M | -39.9% |
| FY2025 | Jun 30, 2025 | $2.07M | +119.0% |
| FY2024 | Jun 30, 2024 | $943.00K | -23.5% |
| FY2023 | Jun 30, 2023 | $1.23M | -69.9% |
| FY2022 | Jun 30, 2022 | $4.09M | +34.1% |
| FY2021 | Jun 30, 2021 | $3.05M | +127.8% |
| FY2020 | Jun 30, 2020 | $1.34M | +308.2% |
| FY2019 | Jun 30, 2019 | $328.00K | -71.9% |
| FY2018 | Jun 30, 2018 | $1.17M | +194.2% |
| FY2017 | Jun 30, 2017 | $397.00K | – |
| FY2016 | Jun 30, 2016 | -$594.00K | – |
| FY2015 | Jun 30, 2015 | -$113.00K | -106.0% |
| FY2014 | Jun 30, 2014 | $1.88M | – |
| FY2013 | Jun 30, 2013 | -$1.44M | – |
| FY2012 | Jun 30, 2012 | -$771.00K | -296.7% |
| FY2011 | Jun 30, 2011 | $392.00K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | -$1.19M | -302.0% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $517.00K | -16.1% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $617.00K | +207.0% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $1.30M | +98.0% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $591.00K | – |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $616.00K | -62.5% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $201.00K | – |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $657.00K | -50.0% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | -$186.00K | – |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $1.64M | +11.8% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | -$1.83M | – |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $1.31M | +32.4% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | -$1.19M | -143.9% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $1.47M | +117.8% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | -$44.00K | – |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $992.00K | -52.8% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $2.70M | +279.6% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $675.00K | -42.5% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | -$1.39M | – |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $2.10M | +9.5% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $712.00K | – |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $1.17M | -52.9% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | -$754.00K | – |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $1.92M | +13.8% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | -$2.21M | -452.5% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $2.49M | +305.0% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | -$627.00K | – |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $1.69M | +184.1% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $627.00K | – |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $615.00K | -12.5% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | -$1.51M | – |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $593.00K | -63.0% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | -$175.00K | – |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $703.00K | +5.2% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | -$964.00K | -189.8% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $1.60M | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | -$818.00K | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $668.00K | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $1.07M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | -$526.00K | – |
See a number that looks wrong?